Pravastatin Sodium recalls
Pravastatin Sodium products have been recalled 13 times, most recently on 16 Apr 2025. The recalling company is usually Glenmark Pharmaceuticals Inc., USA. The most common reason is manufacturing (cgmp) deviations.
Total recalls 13 since 2013
Last 12 months 0 reported
Class I 0 0% of total
Ongoing 5 latest 16 Apr 2025
Recalls per month, last 24 months click a bar for that month
Severity split
Class I 0 0% Class II 11 85% Class III 2 15%
Why pravastatin sodium is recalled
Ongoing pravastatin sodium recalls 5 active
Reported Class Recall Company Reason Where 16 Apr 2025 Drug CLASS II Pravastatin Sodium Tablets 80mg recalled by Glenmark Pharmaceuticals Pravastatin Sodium Glenmark Pharmaceuticals Inc., USA Manufacturing (CGMP) Deviations Nationwide 16 Apr 2025 Drug CLASS II Pravastatin Sodium Tablets, USP, 20mg, a) recalled Pravastatin Sodium Glenmark Pharmaceuticals Inc., USA Manufacturing (CGMP) Deviations Nationwide 16 Apr 2025 Drug CLASS II Pravastatin Sodium Tablets, 20mg, a) recalled Pravastatin Sodium Glenmark Pharmaceuticals Inc., USA Manufacturing (CGMP) Deviations Nationwide 16 Apr 2025 Drug CLASS II Pravastatin Sodium Tablets, USP, 80mg, a) recalled Pravastatin Sodium Glenmark Pharmaceuticals Inc., USA Manufacturing (CGMP) Deviations Nationwide 24 Jul 2024 Drug CLASS II Pravastatin Sodium Tablets, USP 80mg recalled Pravastatin Sodium Glenmark Pharmaceuticals Inc., USA Potency & Assay Nationwide
All pravastatin sodium recalls, newest first 13 total
Reported Class Recall Company Reason Where 16 Apr 2025 Drug CLASS II Pravastatin Sodium Tablets 80mg recalled by Glenmark Pharmaceuticals Pravastatin Sodium Glenmark Pharmaceuticals Inc., USA Manufacturing (CGMP) Deviations Nationwide 16 Apr 2025 Drug CLASS II Pravastatin Sodium Tablets, USP, 20mg, a) recalled Pravastatin Sodium Glenmark Pharmaceuticals Inc., USA Manufacturing (CGMP) Deviations Nationwide 16 Apr 2025 Drug CLASS II Pravastatin Sodium Tablets, 20mg, a) recalled Pravastatin Sodium Glenmark Pharmaceuticals Inc., USA Manufacturing (CGMP) Deviations Nationwide 16 Apr 2025 Drug CLASS II Pravastatin Sodium Tablets, USP, 80mg, a) recalled Pravastatin Sodium Glenmark Pharmaceuticals Inc., USA Manufacturing (CGMP) Deviations Nationwide 24 Jul 2024 Drug CLASS II Pravastatin Sodium Tablets, USP 80mg recalled Pravastatin Sodium Glenmark Pharmaceuticals Inc., USA Potency & Assay Nationwide 8 Mar 2023 Drug CLASS II Pravastatin Sodium Tablets USP 20 mg recalled by Accord Healthcare Pravastatin Sodium Accord Healthcare Manufacturing (CGMP) Deviations PR 8 Mar 2023 Drug CLASS II Pravastatin Sodium Tablets USP, 10 mg recalled by Accord Healthcare Pravastatin Sodium Accord Healthcare Manufacturing (CGMP) Deviations PR 8 Mar 2023 Drug CLASS II Pravastatin Sodium Tablets USP, 40 mg recalled by Accord Healthcare Pravastatin Sodium Accord Healthcare Manufacturing (CGMP) Deviations PR 8 Mar 2023 Drug CLASS II Pravastatin Sodium Tablets USP, 80 mg recalled by Accord Healthcare Pravastatin Sodium Accord Healthcare Manufacturing (CGMP) Deviations PR 17 Apr 2019 Drug CLASS II Pravastatin Sodium Tablets USP, 20 mg recalled Pravastatin Sodium Glenmark Pharmaceuticals Inc., USA Other Nationwide 29 Nov 2017 Drug CLASS II Pravastatin Sodium USP, tablets, 40 mg recalled by Lupin Pravastatin Sodium Lupin Other Nationwide 9 Aug 2017 Drug CLASS III Pravastatin Sodium Tablets, USP, 10 mg recalled Pravastatin Sodium Dr. Reddy's Laboratories Potency & Assay Nationwide 22 May 2013 Drug CLASS III Glenmark Pravastatin Sodium Tablets ,40 mg bottle recalled Pravastatin Sodium Glenmark Generics Inc. USA Other Nationwide
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.